This indicated that perhaps Bim does not play a central role in drug resistance in neuroblastoma, or alternatively, the acquired resistance in our model mechanistically is driven by a direct BDNF-Bim pathway. The gene discussed is BCL2L11; the disease is neuroblastoma.